DLD and ovarian cancer: Our study revealed that the expression of four core factors of the lipoic acid pathway (i.e., FDX1, DLD, DLAT, and PDHB) was distinct between ovarian cancer patients and normal tissues and that it was significantly correlated with a poor prognosis inovarian cancer patients.